Abstract
Background: It often takes several days or even weeks to establish full enteral feeds (FEFs) in preterm, especially extremely low birthweight neonates because of feed intolerance related to gastrointestinal hypomotility. Clinical trials of erythromycin as a prokinetic agent in preterm neonates have reported conflicting results.Aim: To systematically review the efficacy and safety of erythromycin as a prokinetic agent in preterm neonates.Methods: Only randomised controlled trials in preterm neonates (gestation
| Original language | English |
|---|---|
| Pages (from-to) | F301-F306 |
| Journal | Archives of Disease in Childhood, Fetal and Neonatal Edition |
| Volume | 90 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2005 |